Ciclotizolam

Molecular structure via molpic based on CDK

Conformer []

Conformer structure via 3Dmol.js

Physical properties []
Molecular mass	461.8 g/mol ^[1]
Predicted LogP	4.6 ^[1]

Structural Identifiers []
Molecular formula	C₂₀H₁₈BrClN₄S ^[1]
IUPAC name	4-bromo-7-(2-chlorophenyl)-13-cyclohexyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaene ^[1]
SMILES	C1CCC(CC1)C2=NN=C3N2C4=C(C=C(S4)Br)C(=NC3)C5=CC=CC=C5Cl ^[1]
InChI	InChI=1S/C20H18BrClN4S/c21-16-10-14-18(13-8-4-5-9-15(13)22)23-11-17-24-25-19(26(17)20(14)27-16)12-6-2-1-3-7-12/h4-5,8-10,12H,1-3,6-7,11H2 ^[1]
InChIKey	ZOSHXIXUCKESEG-UHFFFAOYSA-N ^[1]

Ciclotizolam

Ciclotizolam (also known as We 973-BS, Ciclotizolamum, We 973, WE-973-BS, 2-Bromo-4-(o-chlorophenyl)-9-cyclohexyl-6H-thieno(3,2-f)-s-triazolo(4,3-a)(1,4)diazepine, WE-973 or HY-168363) is a substance of the thienotriazolodiazepine class.

Chemistry

Stereochemistry []

Ciclotizolam is a achiral mixture

Legal status []

Canada: Ciclotizolam is a Schedule IV substance.

External links []

References []

National Center for Biotechnology Information. PubChem Compound Summary for CID 71949, Ciclotizolam. Accessed June 26, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/71949
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Ciclotizolam. UNII: JK517QTN4Q. Global Substance Registration System. Accessed June 26, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/JK517QTN4Q

Anodyne